JP2023535453A5 - - Google Patents
Info
- Publication number
- JP2023535453A5 JP2023535453A5 JP2023504746A JP2023504746A JP2023535453A5 JP 2023535453 A5 JP2023535453 A5 JP 2023535453A5 JP 2023504746 A JP2023504746 A JP 2023504746A JP 2023504746 A JP2023504746 A JP 2023504746A JP 2023535453 A5 JP2023535453 A5 JP 2023535453A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- heteroaryl
- pharmaceutically acceptable
- stereoisomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063056168P | 2020-07-24 | 2020-07-24 | |
| US63/056,168 | 2020-07-24 | ||
| US202063113557P | 2020-11-13 | 2020-11-13 | |
| US63/113,557 | 2020-11-13 | ||
| PCT/US2021/042999 WO2022020730A1 (en) | 2020-07-24 | 2021-07-23 | Quinazolinone hsd17b13 inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023535453A JP2023535453A (ja) | 2023-08-17 |
| JP2023535453A5 true JP2023535453A5 (https=) | 2024-07-18 |
Family
ID=79728363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504746A Pending JP2023535453A (ja) | 2020-07-24 | 2021-07-23 | キナゾリノンｈｓｄ１７ｂ１３阻害剤とその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230286923A1 (https=) |
| EP (1) | EP4185380A4 (https=) |
| JP (1) | JP2023535453A (https=) |
| KR (1) | KR20230066554A (https=) |
| CN (1) | CN116194440A (https=) |
| AU (1) | AU2021310936A1 (https=) |
| CA (1) | CA3186951A1 (https=) |
| IL (1) | IL300107A (https=) |
| TW (1) | TW202220964A (https=) |
| WO (1) | WO2022020730A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN202011027502A (https=) * | 2020-06-29 | 2021-12-31 | Council Scient Ind Res | |
| AU2021377248B2 (en) * | 2020-11-13 | 2025-12-18 | Inipharm, Inc. | Dichlorophenol hsd17b13 inhibitors and uses thereof |
| WO2022216626A1 (en) * | 2021-04-05 | 2022-10-13 | Inipharm, Inc. | Hydroxypyridine hsd17b13 inhibitors and uses thereof |
| CN118103038A (zh) | 2021-08-20 | 2024-05-28 | 英安塔制药有限公司 | 17β-羟基类固醇脱氢酶13型抑制剂及其使用方法 |
| WO2023192375A1 (en) * | 2022-03-29 | 2023-10-05 | Fl2022-001, Inc. | Hsd17b13 inhibitors and uses thereof |
| CN114644655B (zh) * | 2022-04-19 | 2023-10-27 | 湖南农业大学 | 一种光催化磷酰化喹唑啉酮类化合物的制备方法 |
| EP4514805A4 (en) * | 2022-04-28 | 2026-01-21 | Enanta Pharm Inc | TYPE 13 17-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS CONTAINING PYRIMIDINONE |
| PL4514782T3 (pl) * | 2022-05-19 | 2026-02-23 | Astrazeneca Ab | Związki amidoheteroaromatyczne przydatne w leczeniu chorób wątroby |
| JP2025523357A (ja) | 2022-06-09 | 2025-07-23 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｈｓｄ１７ｂ１３阻害剤 |
| WO2025024682A1 (en) * | 2023-07-26 | 2025-01-30 | Inipharm, Inc. | Methods of using dichlorophenol hsd17b13 inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2694711A (en) * | 1952-12-02 | 1954-11-16 | American Cyanamid Co | Quinazolone antimalarial compounds |
| JP2005097276A (ja) * | 2003-08-22 | 2005-04-14 | Takeda Chem Ind Ltd | 縮合ピリミジン誘導体およびその用途 |
| US20070010537A1 (en) * | 2004-08-20 | 2007-01-11 | Kazumasa Hamamura | Fused pyramidine derivative and use thereof |
| JP2008543968A (ja) * | 2005-06-28 | 2008-12-04 | オーキッド リサーチ ラボラトリーズ リミテッド | 新規なピラゾロピリミジノン誘導体 |
| ME02420B (me) * | 2006-09-26 | 2016-09-20 | Celgene Corp | 5-supstituirani derivati kinazolinona kao sredstva protiv raka |
| US20080255161A1 (en) * | 2007-04-11 | 2008-10-16 | Dmitry Koltun | 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| US20120165330A1 (en) * | 2010-12-22 | 2012-06-28 | Sirtris Pharmaceuticals, Inc. | Quinazolinone and related analogs as sirtuin modulators |
| JP6359563B2 (ja) * | 2013-01-14 | 2018-07-18 | デュートルクス・リミテッド・ライアビリティ・カンパニーＤｅｕｔｅＲｘ， ＬＬＣ | ３−（５置換−４−オキソキナゾリン−３（４ｈ）−イル）−３−ジュウテロピペリジン−２，６−ジオン誘導体 |
| US11608340B2 (en) * | 2014-11-17 | 2023-03-21 | Rhode Island Hospital | Nanomaterial compositions, synthesis, and assembly |
| KR102331013B1 (ko) * | 2016-01-14 | 2021-11-26 | 강푸 바이오파마슈티칼즈 리미티드 | 퀴나졸리논 유도체, 이의 제조방법, 약학 조성물 및 적용 |
-
2021
- 2021-07-23 KR KR1020237006628A patent/KR20230066554A/ko not_active Ceased
- 2021-07-23 WO PCT/US2021/042999 patent/WO2022020730A1/en not_active Ceased
- 2021-07-23 TW TW110127238A patent/TW202220964A/zh unknown
- 2021-07-23 CN CN202180065725.7A patent/CN116194440A/zh active Pending
- 2021-07-23 IL IL300107A patent/IL300107A/en unknown
- 2021-07-23 AU AU2021310936A patent/AU2021310936A1/en not_active Abandoned
- 2021-07-23 CA CA3186951A patent/CA3186951A1/en active Pending
- 2021-07-23 EP EP21845951.9A patent/EP4185380A4/en not_active Withdrawn
- 2021-07-23 JP JP2023504746A patent/JP2023535453A/ja active Pending
- 2021-07-23 US US18/006,062 patent/US20230286923A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023535453A5 (https=) | ||
| JP2024514223A5 (https=) | ||
| JP2023537271A5 (https=) | ||
| JP2024520481A5 (https=) | ||
| JP2024543976A5 (https=) | ||
| JP2024050527A5 (https=) | ||
| JP2018504437A5 (https=) | ||
| RU2017112048A (ru) | Синергистические комбинации ауристана | |
| RU2009109949A (ru) | Соединения для лечения пролиферативных расстройств | |
| JP2010501562A5 (https=) | ||
| JP2021534108A5 (https=) | ||
| RU2019100164A (ru) | Гетероциклическое соединение, используемое как ингибитор fgfr | |
| JP2015531773A5 (https=) | ||
| JP2019522055A5 (https=) | ||
| JP2023553835A5 (https=) | ||
| JP2011037841A5 (https=) | ||
| JP2011057693A5 (https=) | ||
| JP2017537940A5 (https=) | ||
| JP2014511840A5 (https=) | ||
| JP2010501584A5 (https=) | ||
| JP2023541522A5 (https=) | ||
| JP2010509366A5 (https=) | ||
| JP2015523339A5 (https=) | ||
| AU2006272652B2 (en) | 1,2,3-triazoles inhibitors of tubulin polymerization for the treatment of proliferative disorders | |
| RU2007124329A (ru) | ПРОИЗВОДНЫЕ 5-ГИДРОКСИБЕНЗОТИАЗОЛА В КАЧЕСТВЕ АГОНИСТОВ β2 АДРЕНОРЕЦЕПТОРОВ |